SpaceX Stock Climbs Back Above Its $135 IPO Price -- Here's Where It Could Trade by August 2027

SpaceX stock closed Aug. 12 at $146.15, above its $135 IPO price, after delivering a strong Q2: revenue rose 92% to $7.8B with an improved net loss of $542M vs. $1.0B a year earlier. Analysts are broadly bullish, with a median one-year price target of $217 (about +48.4% from $146.15). The article flags volatility risk and notes the share price remains below the $150 level where it opened its first day.

Analysis

The market is no longer pricing this as a pure story-stock bounce; it is testing whether incremental supply from the lockup can be absorbed without breaking the tape. That matters because the first-order winner is not just existing holders — it is the company’s future financing flexibility: if the float can clear a supply overhang at this valuation, any later equity raise or strategic secondary should be less punitive. The loser is the short thesis built around insider selling; that narrative loses credibility when price stabilizes despite expected supply.

The real driver is operating leverage, not the headline growth rate. If revenue can compound at this pace while losses continue narrowing, the multiple can stay elevated even in a higher-rate environment, but only if capex and launch cadence don’t outrun gross profit. The key near-term risk is that one soft quarter — whether from launch timing, customer concentration, or lower monetization quality — can hit both growth and sentiment at once; that is a days-to-weeks risk, while the margin/FCF debate is 6-18 months.

The consensus seems to be underweighting how quickly sentiment can re-rate once a feared supply event fails to materialize, but also underappreciating how fragile that re-rating is if management leans into dilution or insiders use strength to sell. There is no broad read-through to NDAQ, NFLX, NVDA, or TGT; this is a single-name momentum/positioning event. The contrarian view is that the move may be more about positioning than fundamentals, so chasing strength here is lower-quality than buying a pullback with a defined stop.

Key Decisions for Investors

• Long SPCX on a pullback into the $135-140 area over the next 2-4 weeks; target a retest of the post-IPO high zone, with thesis invalidation on a weekly close below $125 or any announced secondary offering.
• Pair trade for 1-3 months: long SPCX / short RKLB as a relative-value expression of scale, operating leverage, and financing quality in space. Cover the short if RKLB shows a launch/share gain or if SPCX growth visibly decelerates next quarter.
• Do not chase SPCX after a straight-line move above IPO price; wait for the next earnings print or insider-sale update to confirm that post-lockup supply is truly absorbed. If the stock loses $135 on closing basis before that catalyst, fade the rally rather than add.
• Watch item, not trade: if management signals equity-funded expansion or another large insider distribution window opens, expect multiple compression over the next 1-3 months and reduce long exposure.